US FDA identifies recall of Philips’ respiratory devices as most serious

THE US Food and Drug Administration (FDA) on Friday (Apr 7) classified the recall of Philips’ respiratory machines as its most serious type, as their use could cause serious injuries or death.

The Dutch medical devices maker’s unit Philips Respironics recalled 1,088 devices in the US on Feb 10.

These devices help people with respiratory conditions to keep breathing at a regular rhythm.

Philips was recalling the machines as some devices were assigned incorrect or duplicate serial numbers during initial programming, the US health agency said.

The duplication could cause therapy to be delivered using the wrong prescription or factory default settings, it added.

The company has received 43 complaints about the issue, according to the FDA. It said there were currently no reported injuries or deaths attributed to it.

SEE ALSO

Italy orders Philips to fast-track recall of sleep apnea devices

DECODING ASIA

Navigate Asia in
a new global order

Get the insights delivered to your inbox.

The devices were distributed between Dec 1, 2021 and Oct 31, last year.

The company said affected units may continue to be used in accordance with device instructions, adding that it was reaching out to patients to arrange for the units’ replacement and return. REUTERS